OptimizeRx to Present at RBC Capital Markets Global Healthcare Virtual Conference on May 19, 2020
18 Mai 2020 - 10:01PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, payers and providers,
has been invited to present in RBC Capital Markets virtual Global
Healthcare Conference: "Beyond 2020: The Changing Face of
Healthcare.” The event is being held on May 19-20, 2020.
The event aims to dig deeper across sectors into how the
healthcare industry will emerge out of the COVID-19 pandemic,
uncovering new approaches to innovation, such as digital health,
future trends in industry collaboration and consolidation, and
political and macro-economic influences.
OptimizeRx CEO William Febbo is scheduled to present on May 19,
2020, at 8:35 a.m. Eastern time, as well as participate in virtual
one-on-one meetings. He will discuss a number of topics, including
the company’s record Q1 results, client base that includes world’s
Top 20 pharmaceutical companies, and how the company is supporting
better health outcomes through its digital health network that now
reaches 60% of the ambulatory market and patients nationwide.
The live presentation will be available at
investors.optimizerx.com/events-and-presentations.
The event is for institutional clients of RBC and is by
invitation only. To schedule a one-on-one meeting with OptimizeRx,
please contact your RBC sales representative. For any questions
about OptimizeRx, contact Ron Both of CMA at (949) 432-7557 or
submit your request here.
About OptimizeRx®OptimizeRx
Corporation (NASDAQ: OPRX) is a digital health company that
facilitates communication at point-of-care among all stakeholders
in healthcare. Primarily focused on life science and payer clients,
its suite of digital and mobile SaaS-based solutions enables
affordability, patient adherence and care management. OptimizeRx’s
network reaches more than 60% of U.S. ambulatory providers,
delivering therapeutic support on specialty medications and patient
financial assistance directly within a provider’s workflow through
leading electronic health platforms. OptimizeRx’s fully integrated
platform supports the real-time exchange of information, improving
provider knowledge and patient engagement, and ultimately leading
to healthier outcomes.
For more information, go to OptimizeRx.com, and follow the
company on Twitter and LinkedIn.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
OptimizeRx Contact Doug Baker, CFOTel (248)
651-6568 x807 dbaker@optimizerx.com
Media Relations Contact Maira Alejandra, Media
Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both or Grant
StudeCMA Investor RelationsTel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024